CYTARINE 100MG INJECTION

Cytarine 100mg Injection contains cytarabine, a prescription antimetabolite chemotherapy medicine widely used in the treatment of acute leukemias, particularly acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL). It works by inhibiting DNA synthesis in rapidly dividing cancer cells, leading to cell death and suppression of abnormal cell proliferation. This injection is administered strictly under medical supervision in hospital settings.

Cytarine 100 mg Injection is commonly prescribed as part of induction, consolidation, or maintenance therapy in leukemia treatment protocols. By targeting fast-growing malignant cells, this anticancer product helps control disease progression and improve treatment response. Due to its potent mechanism of action, careful dosing, monitoring, and administration by qualified healthcare professionals are essential to ensure safety and therapeutic effectiveness.

Cytarine 100 mg Injection is widely used in clinical oncology and haematology for the effective management of acute leukemias. This product is supplied for use in hospitals, oncology centers, and specialized treatment facilities and is available for bulk supply and international distribution. Cytarine 100 mg Injection remains a trusted therapeutic option when administered under controlled medical supervision.

Product Features

• Effective anticancer chemotherapy injection
• Contains Cytarabine 100 mg
• Antimetabolite (pyrimidine analog)
• Used in acute leukemia treatment
• Administered intravenously or subcutaneously
• Sterile injectable formulation
• Manufactured under GMP-compliant standards
• Prescription-required oncology medicine

How It Helps

• Inhibits DNA synthesis in rapidly dividing leukemia cells
• Promotes cancer cell death to control disease progression
• Supports induction and consolidation therapy in acute leukemia
• Helps improve treatment response under medical supervision